[
  {
    "ts": null,
    "headline": "Dividend Income: Bert's September Dividend Income Summary",
    "summary": "In May, we earned $5,140.66 in dividend income. That is a 19% dividend increase compared to last year. Read more here.",
    "url": "https://finnhub.io/api/news?id=f0f347ced2c6d2af79bfc7508fe6ee4d0be5946cc7a9ba1a6763544286f5827e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761499080,
      "headline": "Dividend Income: Bert's September Dividend Income Summary",
      "id": 137213588,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166399130/image_2166399130.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "In May, we earned $5,140.66 in dividend income. That is a 19% dividend increase compared to last year. Read more here.",
      "url": "https://finnhub.io/api/news?id=f0f347ced2c6d2af79bfc7508fe6ee4d0be5946cc7a9ba1a6763544286f5827e"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend Stocks With Yields Over 5%. Should You Buy?",
    "summary": "Dividend investing offers a reliable path to passive income and long-term wealth building, especially when stock prices stagnate or decline. Regular payouts provide cash flow regardless of market direction, and reinvesting dividends historically drives much of total return. High-yield stocks, however, carry risks. Yields above 5% often signal underlying issues—declining earnings, high debt, or sector-specific ... 3 Dividend Stocks With Yields Over 5%. Should You Buy?",
    "url": "https://finnhub.io/api/news?id=95d86a5572a3f5ef8e2c50afccd0b14116817106820fe0c9a938f1f46ca9098b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761488239,
      "headline": "3 Dividend Stocks With Yields Over 5%. Should You Buy?",
      "id": 137216025,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Dividend investing offers a reliable path to passive income and long-term wealth building, especially when stock prices stagnate or decline. Regular payouts provide cash flow regardless of market direction, and reinvesting dividends historically drives much of total return. High-yield stocks, however, carry risks. Yields above 5% often signal underlying issues—declining earnings, high debt, or sector-specific ... 3 Dividend Stocks With Yields Over 5%. Should You Buy?",
      "url": "https://finnhub.io/api/news?id=95d86a5572a3f5ef8e2c50afccd0b14116817106820fe0c9a938f1f46ca9098b"
    }
  },
  {
    "ts": null,
    "headline": "Meet all 37 White House ballroom donors funding the $300 million build, including Silicon Valley tech giants, crypto bros and the Lutnicks",
    "summary": "The list, reviewed by Fortune, did not mention specific dollar amounts offered by each contributor.",
    "url": "https://finnhub.io/api/news?id=79f6887eb70e9903dcfb7015e4e03eaadeecd136b6c99773f66ddd72cc8ab967",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761469380,
      "headline": "Meet all 37 White House ballroom donors funding the $300 million build, including Silicon Valley tech giants, crypto bros and the Lutnicks",
      "id": 137228567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The list, reviewed by Fortune, did not mention specific dollar amounts offered by each contributor.",
      "url": "https://finnhub.io/api/news?id=79f6887eb70e9903dcfb7015e4e03eaadeecd136b6c99773f66ddd72cc8ab967"
    }
  },
  {
    "ts": null,
    "headline": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.",
    "summary": "Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).",
    "url": "https://finnhub.io/api/news?id=3ea17542bbe30a846d97b638ab8e19876cadfb13254d95ca591e8d687c0d2e0f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761465600,
      "headline": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.",
      "id": 137216026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).",
      "url": "https://finnhub.io/api/news?id=3ea17542bbe30a846d97b638ab8e19876cadfb13254d95ca591e8d687c0d2e0f"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ): Evaluating Valuation After Recent Share Gains and Growth Outlook",
    "summary": "Johnson & Johnson (JNJ) shares have edged mostly sideways over the past week, finishing at $190.40 in the latest session. Investors are weighing the company’s recent performance as revenue and net income both show modest annual growth. See our latest analysis for Johnson & Johnson. Johnson & Johnson’s share price has rallied impressively in 2024, notching a 32.2% year-to-date gain that reflects renewed optimism after a period of volatility. Despite a minor pullback in the past week, momentum...",
    "url": "https://finnhub.io/api/news?id=5747d262ddde32fe89c3191b1649fd1d32455a906859c5a34a5207c4556dd893",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761448087,
      "headline": "Johnson & Johnson (JNJ): Evaluating Valuation After Recent Share Gains and Growth Outlook",
      "id": 137216027,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) shares have edged mostly sideways over the past week, finishing at $190.40 in the latest session. Investors are weighing the company’s recent performance as revenue and net income both show modest annual growth. See our latest analysis for Johnson & Johnson. Johnson & Johnson’s share price has rallied impressively in 2024, notching a 32.2% year-to-date gain that reflects renewed optimism after a period of volatility. Despite a minor pullback in the past week, momentum...",
      "url": "https://finnhub.io/api/news?id=5747d262ddde32fe89c3191b1649fd1d32455a906859c5a34a5207c4556dd893"
    }
  }
]